Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Immunostimulatory sequence designed by Dynavax reduces HSV-2 severity

March 30, 2000

Development and use of gene-based multivalent malaria vaccine

March 28, 2000

Glaxo Wellcome expands DNA vaccine program with PowderJect

March 28, 2000

Siga acquires Chlamydia vaccine technology from Oregon State University

March 27, 2000

Vasogen cleared to proceed with clinical trial of VAS-981 in leukemia patients

March 24, 2000

IND filed with FDA for ISAtx-247

March 23, 2000

Effects of TAK-603 on cytokine production reported at Japanese congress

March 22, 2000

Medinox's NO neutralizer prevents transplant rejection in preclinical study

March 21, 2000

Whole genome sequencing of N. meningitidis leads to novel vaccine candidates

March 20, 2000

SangStat files NDA in Canada for Thymoglobulin

March 17, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.